Experimental device tested to control aggressive brain tumor growth
Disease control
Completed
This study tested a medical device called NOVOTTF-200A in adults with a recurrent, aggressive type of brain tumor called grade 3 astrocytoma. The main goal was to see if the device could help control the tumor's growth for at least six months in patients who had not received a sp…
Phase: NA • Sponsor: Daniela A. Bota • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC